US Patent Issued to AVIDITY BIOSCIENCES on Sept. 9 for "Compositions comprising PLN-targeting anti-transferrin receptor antibody-polynucleotides and methods of use thereof to treat cardiomyopathy" (California Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,230, issued on Sept. 9, was assigned to AVIDITY BIOSCIENCES INC. (San Diego).

"Compositions comprising PLN-targeting anti-transferrin receptor antibody-polynucleotides and methods of use thereof to treat cardiomyopathy" was invented by Cecilia Hurtado (San Diego), Georgios Karamanlidis (Thousand Oaks, Calif.), Sami Abdulwahab Abdulkadir (San Diego), Subbarao Nallagatla (San Diego) and Maryam Jordan (Escondido, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods of use for antibody-PLN targeting oligonucleotide conjugates (AOC)."

The patent was filed on June...